Seed investors in NYC

IP

ISA Pharmaceuticals B.V.

Technology Company

Worked at ISA Pharmaceuticals B.V.

Mark Krul

Chief Executive Officer at Inthera Bioscience AG

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.